Earnings Call · Q1 FY2021·2021-04-30

Q1 21EPS +10.78%·Rev n/aQ4 20EPS -1.57%·Rev n/aQ3 20EPS +13.30%·Rev n/aQ2 20EPS +25.48%·Rev n/a⚠ consensus missing

VERTEX PHARMACEUTICALS INC / MA VRTX

Company Representatives

Michael Partridge — Senior Vice President of Investor Relations

Dr. Reshma Kewalramani — Chief Executive Officer, President

Stuart Arbuckle — Chief Commercial and Operations Officer

Charles Wagner — Chief Financial Officer

−0.1%1d on move date3d−2.0%5d−1.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VRTX calls or request research access.

More VRTX calls Browse calls Request research access